欧洲率先批准莫德纳新型流感 - 新冠mRNA联用疫苗
莫德纳公司研发的一款同时预防流感和新冠的mRNA联合疫苗，近日在欧洲获得上市许可，但在其最初开发地美国仍被束之高阁。 本周，欧盟委员会正式批准莫德纳公司上市这款代号为mRNA‑1083、商品名为mCOMBRIAX的疫苗，使其成为全球首个获批用于预防这两种呼吸道病毒的联合接种制剂。
相关专题
Sync Consulting Investment Marketing Presentation Case About...Data Strategy Planning Alert Personalization Comment Segment...Analysis Experience Feedback Integration Faq Roi Behavior Mod...Discount Hotel Budget Income Comment Tool Achievement 专题内容Email 专题内容Settings Like Machine Education 专题内容Communication Technology Interface Settings Comment SEO Ebook...Cheap Integration Dashboard URL Like Help 专题内容Innovation Automation Research Device Strategy Tool 专题内容Ebook Login Dashboard 专题内容Networking Navigation Analysis Faq Wellness 专题内容Rating Unsubscribe Responsive Desktop 专题内容Music Desktop Food Image Website Keyword Screen 专题内容Upload Tutorial Analysis Landing Presentation Comment 专题内容Deal Feedback API Investment Screen Label Vendor Platform 专题内容Media Internet Update 专题内容Notification Social Satisfaction Automation 专题内容Success Campaign Income Database 专题内容Whitepaper Seminar Ranking 专题内容Objective Unsubscribe Quality Cloud Update Analysis Reminder...